Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth

Stock Track

Feb 04

Bio-Techne's stock surged 5.14% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.

The life sciences company reported adjusted earnings per share of $0.46 for the quarter, beating analyst estimates of $0.43 and representing a 9.5% increase compared to the same period last year. Revenue came in at $295.88 million, also surpassing expectations of $290.19 million.

The strong performance was driven by several key factors, including double-digit growth in its large pharma end-market for the fourth consecutive quarter and ongoing expansion in the China/APAC region for the third straight quarter. The company also achieved an improved adjusted operating margin of 31.1%, supported by productivity initiatives and cost containment measures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1112355393"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112355393\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112355393?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 23:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112355393","market":"nz","top_or_hot":-1,"title":"Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth","media":"Stock Track","content":"<p>Bio-Techne's stock surged 5.14% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.</p><p>The life sciences company reported adjusted earnings per share of $0.46 for the quarter, beating analyst estimates of $0.43 and representing a 9.5% increase compared to the same period last year. Revenue came in at $295.88 million, also surpassing expectations of $290.19 million.</p><p>The strong performance was driven by several key factors, including double-digit growth in its large pharma end-market for the fourth consecutive quarter and ongoing expansion in the China/APAC region for the third straight quarter. The company also achieved an improved adjusted operating margin of 31.1%, supported by productivity initiatives and cost containment measures.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-04 23:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bio-Techne's stock surged 5.14% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.</p><p>The life sciences company reported adjusted earnings per share of $0.46 for the quarter, beating analyst estimates of $0.43 and representing a 9.5% increase compared to the same period last year. Revenue came in at $295.88 million, also surpassing expectations of $290.19 million.</p><p>The strong performance was driven by several key factors, including double-digit growth in its large pharma end-market for the fourth consecutive quarter and ongoing expansion in the China/APAC region for the third straight quarter. The company also achieved an improved adjusted operating margin of 31.1%, supported by productivity initiatives and cost containment measures.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TECH","symbol_name":"Techne Corporation","start_time":0,"source_url":"","article_id":"1112355393","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112355393","pubTimestamp":1770217537,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Bio-Techne's stock surged 5.14% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.The life sciences company reported adjusted earnings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TECH":"Techne Corporation"},"translate_title":"股票追踪|Bio-Techne盘前飙升5.14%，因第二季度盈利强劲增长和中国/亚太地区增长","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TECH":1},"content_text":"Bio-Techne's stock surged 5.14% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.The life sciences company reported adjusted earnings per share of $0.46 for the quarter, beating analyst estimates of $0.43 and representing a 9.5% increase compared to the same period last year. Revenue came in at $295.88 million, also surpassing expectations of $290.19 million.The strong performance was driven by several key factors, including double-digit growth in its large pharma end-market for the fourth consecutive quarter and ongoing expansion in the China/APAC region for the third straight quarter. The company also achieved an improved adjusted operating margin of 31.1%, supported by productivity initiatives and cost containment measures.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}